Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B
NCT02249988
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
261
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
ABX203 therapeutic Hepatitis B vaccine treatment arm
Sponsor
Abivax S.A.